Institution identification

PURI

https://redirect.ema.europa.eu/resource/3331188

Institution ID

3331188

Institution full name and acronym

Finnish Institute for Health and Welfare (THL)

Institution countries

Finland

Type of institution

Educational Institution
Laboratory/Research/Testing facility

Institution role

Data holder
Data provider

ENCePP partner

No
Institution details
Experience with collecting data directly from individual patients or respondents:
No
Interest in carrying out research that is funded by pharmaceutical companies:
No

Contact

Studies conducted by the institution

Demonstrating solutions for studying intermittent medication exposures in diseases with episodic manifestations during pregnancy: application to medication for migraine in pregnancy
Drug transporter protein -mediated drug interactions during pregnancy and offspring outcome; with special emphasis on second-generation antipsychotics and
SSRIs (PgP and BCRP interactions and pregnancy)
Effectiveness of monovalent XBB.1.5-containing Covid-19 mRNA vaccines in the Nordic countries
Safety of the second generation antipsychotics during pregnancy (Second generation antipsychotics and pregnancy)
Studying drug exposure when disease is measured through accurate identification of an incident case: application to breast cancer in pregnancy (ConcePTION breast cancer demo)
The utilisation of antiepileptics in men and women of childbearing age, and pregnant women in Europe (ADEPT)